Oaktree Acquisition Corp III Life Sciences - Class A

Research Oaktree Acquisition Corp III Life Sciences - Class A (OACC) on Bullrun: valuation model: 19.9% undervalued, market cap USD 263.04M, P/E 37.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOACC
• ExchangeNASDAQ
• CountryUnited States
• SectorFinancial Services
• IndustryShell Companies
• CurrencyUSD
• Valuation signal19.9% undervalued
• Market capUSD 263.04M
• P/E37.5
• Financial periodFY2025
• Net incomeUSD 7.29M

Valuation Snapshot

Bullrun's latest valuation model marks Oaktree Acquisition Corp III Life Sciences - Class A as 19.9% undervalued; latest market cap is USD 263.04M; P/E is 37.5.

About Oaktree Acquisition Corp III Life Sciences - Class A

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Frequently asked questions

Is Oaktree Acquisition Corp III Life Sciences - Class A overvalued or undervalued?

Bullrun's valuation model currently marks Oaktree Acquisition Corp III Life Sciences - Class A as 19.9% undervalued.

What is Oaktree Acquisition Corp III Life Sciences - Class A's market cap?

Oaktree Acquisition Corp III Life Sciences - Class A's market capitalization is USD 263.04M.

What is Oaktree Acquisition Corp III Life Sciences - Class A's P/E ratio?

Oaktree Acquisition Corp III Life Sciences - Class A's price-to-earnings (P/E) ratio is 37.5.

What does Oaktree Acquisition Corp III Life Sciences - Class A do?

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.